Peter Kolchinsky, Director, 10% Owner at Eliem Therapeutics, Inc. (ELYM), bought 27,437,589 shares at $3.84 ($95.8M) on 2024-06-27, disclosed to the SEC on 2024-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,479,872 | $0 | 0.0% |
| 2 | $3.84 | 1,059,375 | $4.1M | 4.2% |
| 3 | $3.84 | 11,949,171 | $45.9M | 47.9% |
| 4 | $3.84 | 11,949,171 | $45.9M | 47.9% |
| Total | $3.49 avg | 27,437,589 | $95.8M | 100% |
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |